Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?

BACKGROUND: Metformin, statin and aspirin use seem associated with decreased mortality in cancer patients, though, without adjusting for one another. Independent associations of these drugs with overall mortality after colorectal cancer (CRC) diagnosis within glucose-lowering drugs (GLDs) users were...

Descripción completa

Detalles Bibliográficos
Autores principales: Zanders, M M J, van Herk-Sukel, M P P, Vissers, P A J, Herings, R M C, Haak, H R, van de Poll-Franse, L V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522645/
https://www.ncbi.nlm.nih.gov/pubmed/26180924
http://dx.doi.org/10.1038/bjc.2015.259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522645/
https://www.ncbi.nlm.nih.gov/pubmed/26180924
http://dx.doi.org/10.1038/bjc.2015.259

Ejemplares similares